Prospective, Randomized, Double Blind Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Adult Patients With Isolated Growth Hormone Deficiency (PRO ISO-GHD Study) (IGHD)

NCT00630487 Phase 3 TERMINATED Results posted

The study will investigate the effect on growth hormone replacement in patients with isolated growth hormone deficiency on body composition, especially visceral fat mass.

Details

Lead sponsor	Pfizer
Phase	Phase 3
Status	TERMINATED
Enrolment	9
Start date	2008-05
Completion	2008-10

Conditions

• Growth Hormone Deficiency

Interventions

• Placebo
• Somatropin

Primary outcomes

• Change of Visceral Fat Mass Assessed by Magnetic Resonance Imaging Scanning (MRI) — Baseline, 52 weeks
  Fat measurements carried out with the subjects lying in a supine position in a MRI scanner. Measurements of regional body fat obtained between the level of the coccygeal bone and the 2nd or 3rd lumbar vertebra.

Countries

Germany